0001104659-15-013147.txt : 20150223
0001104659-15-013147.hdr.sgml : 20150223
20150223214159
ACCESSION NUMBER: 0001104659-15-013147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150219
FILED AS OF DATE: 20150223
DATE AS OF CHANGE: 20150223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linde North America, Inc.
CENTRAL INDEX KEY: 0001505451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 15641680
BUSINESS ADDRESS:
STREET 1: 575 MOUNTAIN AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 908-771-4757
MAIL ADDRESS:
STREET 1: 575 MOUNTAIN AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
a4.xml
4
X0306
4
2015-02-19
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001505451
Linde North America, Inc.
575 MOUNTAIN AVENUE
MURRAY HILL
NJ
07974
0
0
1
0
Common Stock
2015-02-19
4
P
0
358916
12
A
1629804
D
/s/ Jens Luehring, Chief Financial Officer and Director
2015-02-23